Marion Poenisch

Title: Marion Poenisch: Innovator in Biomedicine

Introduction

Marion Poenisch is a prominent inventor based in Tübingen, Germany. She has made significant contributions to the field of biomedicine, particularly in the development of therapeutic nucleic acids. With a total of 2 patents, her work is paving the way for advancements in medical treatments.

Latest Patents

One of her latest patents is titled "Nucleic acids encoding CRISPR-associated proteins and uses thereof." This invention focuses on artificial nucleic acids, specifically RNAs, that encode CRISPR-associated proteins. The patent outlines a pharmaceutical composition and a kit-of-parts that include these artificial nucleic acids. Furthermore, it discusses their application in medicine, particularly for the treatment and prophylaxis of diseases that can be addressed using CRISPR-associated proteins.

Career Highlights

Marion Poenisch is currently associated with CureVac SE, a company known for its innovative approaches in the field of mRNA technology. Her work at CureVac SE has been instrumental in advancing therapeutic solutions that leverage the potential of CRISPR technology.

Collaborations

Marion has collaborated with notable colleagues, including Frédéric Chevessier-Tünnesen and Thomas Schlake. These collaborations have further enriched her research and development efforts in biomedicine.

Conclusion

Marion Poenisch is a trailblazer in the field of biomedicine, with her innovative patents and contributions to therapeutic nucleic acids. Her work continues to influence the landscape of medical treatments and holds promise for future advancements.